Latest updates for Nvamd

Fresh curated links around NVAMD are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Merck initiates Phase 2b/3 trial for treatment of age-related macular degeneration
  • Can Age-Related Macular Degeneration (AMD) Be Prevented?
  • AMD: Still Good As Number 2

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

roi-nj.com /1 month ago

Merck initiates Phase 2b/3 trial for treatment of age-related macular degeneration

Rahway-based Merck announced the initiation of a pivotal Phase 2b/3 trial evaluating MK-8748 (also known as Tiespectus, EYE201). It is a novel investigational bispecific antibody t...

Read source
zoomer.com /1 month ago

Can Age-Related Macular Degeneration (AMD) Be Prevented?

Age-related macular degeneration, better known by the acronym AMD, is one of the leading causes of vision loss in people aged 50 and over. It affects the macula, the central area o...

Read source
seekingalpha.com /4 days ago

AMD: Still Good As Number 2

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Nvamd

seekingalpha.com

Recent coverage from public sources
Public source

everythingzoomer.com

Recent coverage from public sources
Public source

roi-nj.com

Recent coverage from public sources
Public source